Regional systems of care demonstration project: Mission: Lifeline STEMI Systems Accelerator: design and methodology

American Heart Journal
Akshay BagaiChristopher B Granger

Abstract

ST-segment elevation myocardial infarction (STEMI) systems of care have been associated with significant improvement in use and timeliness of reperfusion. Consequently, national guidelines recommend that each community should develop a regional STEMI care system. However, significant barriers continue to impede widespread establishment of regional STEMI care systems in the United States. We designed the Regional Systems of Care Demonstration Project: Mission: Lifeline STEMI Systems Accelerator, a national educational outcome research study in collaboration with the American Heart Association, to comprehensively accelerate the implementation of STEMI care systems in 17 major metropolitan regions encompassing >1,500 emergency medical service agencies and 450 hospitals across the United States. The goals of the program are to identify regional gaps, barriers, and inefficiencies in STEMI care and to devise strategies to implement proven recommendations to enhance the quality and consistency of care. The study interventions, facilitated by national faculty with expertise in regional STEMI system organization in partnership with American Heart Association representatives, draw upon specific resources with proven past effectiveness in...Continue Reading

Associated Clinical Trials

References

Dec 12, 2002·Journal of the American College of Cardiology·Robert M CaliffUNKNOWN American Heart Association
Mar 30, 2006·Circulation·Alice K JacobsUNKNOWN American Heart Association's Acute Myocardial Infarction Advisory Working Group
Oct 31, 2006·American Heart Journal·James G JollisChristopher B Granger
Nov 6, 2007·JAMA : the Journal of the American Medical Association·James G JollisUNKNOWN Reperfusion of Acute Myocardial Infarction in North Carolina Emergency Departments (RACE) Investigators
May 21, 2009·BMJ : British Medical Journal·Saif S RathoreUNKNOWN National Cardiovascular Data Registry
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·Shailja V ParikhElizabeth M Holper
Mar 24, 2012·The American Journal of Cardiology·Lindsay G SmithTimothy D Henry
Jun 6, 2012·Circulation·James G JollisUNKNOWN Regional Approach to Cardiovascular Emergencies (RACE) Investigators
Nov 10, 2012·American Heart Journal·Colin J ForsythJoel A Strom

❮ Previous
Next ❯

Citations

Oct 31, 2015·Brain and Behavior·James P RhudyAnne W Alexandrov
Jan 14, 2017·Circulation. Cardiovascular Interventions·Christopher B FordyceUNKNOWN STEMI Systems Accelerator Project
May 22, 2016·Journal of the American Heart Association·James R LangabeerDaniela Gerard
Aug 3, 2016·Circulation·James G JollisUNKNOWN Mission: Lifeline STEMI Systems Accelerator Project
Mar 4, 2017·Circulation·Thomas M MaddoxUNKNOWN American Heart Association Council on Quality of Care and Outcomes Research; Council on Cardiovascular Disease in the Young;
Jun 7, 2014·Circulation Research·Akshay BagaiChristopher B Granger
Jul 1, 2016·European Heart Journal. Quality of Care & Clinical Outcomes·Bárbara Campos Abreu MarinoMilena Soriano Marcolino
Mar 2, 2021·Circulation. Cardiovascular Quality and Outcomes·Josephine L Harrington, Christopher B Granger
Jun 1, 2021·Interventional Cardiology Clinics·Dan D Nguyen, Jacob A Doll

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.